We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
126 hedge funds and large institutions have $118M invested in Anika Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
567% more call options, than puts
Call options by funds: $40K | Put options by funds: $6K
120% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 10
59% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 34
8% more funds holding
Funds holding: 117 → 126 (+9)
2% more capital invested
Capital invested by funds: $115M → $118M (+$2.8M)
0.16% more ownership
Funds ownership: 84.84% → 85% (+0.16%)
Holders
126
Holders Change
+9
Holders Change %
+7.69%
% of All Funds
1.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
54
Reduced
34
Closed
10
Calls
$40K
Puts
$6K
Net Calls
+$34K
Net Calls Change
+$43K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$3.62M |
| 2 |
Two Sigma Investments
New York
|
+$1.47M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.17M |
| 4 |
Goldman Sachs
New York
|
+$957K |
| 5 |
Two Sigma Advisers
New York
|
+$858K |
Top Sellers
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$13.9M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.02M |
| 3 |
BlackRock
New York
|
-$835K |
| 4 |
Millennium Management
New York
|
-$582K |
| 5 |
CM
Capital Management
Glen Allen,
Virginia
|
-$486K |
